Morning Market Losers

Coronado Biosciences

plummeted 67.42% to $1.88 after the company reported that top-line results from Trust-I Phase 2 trial of TSO for Crohn's did not meet primary endpoint. Optibase

dropped 16.57% to $5.74. Optibase's trailing-twelve-month ROA is 1.92%. Broadway Financial

dropped 13.07% to $0.93. Broadway Financial shares have dropped 10.08% over the past 52 weeks, while the S&P 500 index has gained 18.27% in the same period. Merus Labs International

dropped 8.97% to $1.3290. Merus Labs International's trailing-twelve-month profit margin is -94.60%.